Key Takeaways
-
Selling an Arizona dental group to a DSO follows a structured, multi-phase process that can span several months and requires careful preparation at every stage.
-
Valuation starts with a defensible, CPA-led EBITDA analysis that documents all add-backs and compares private-buyer and DSO market values.
-
McLerran & Associates negotiates critical LOI terms, including cash at close, equity structure, and earnouts, before exclusivity limits seller leverage.
-
Quality-of-earnings defense and associate retention planning can help protect the agreed valuation through due diligence and reduce the risk of post-LOI price reductions.
-
McLerran & Associates guides Arizona sellers through the entire DSO transaction; schedule a confidential valuation conversation to learn what your group may be worth.
Valuation & Preparation for Arizona Dental Groups
Arizona dental groups with $5M or more in annual collections usually start valuation with EBITDA. EBITDA means earnings before interest, taxes, depreciation, and amortization, adjusted for owner-specific and one-time expenses. Every add-back, such as a personal vehicle, above-market owner compensation, or a one-time equipment purchase, needs clear documentation that can stand up to buyer review.
The difference between a doctor-to-doctor valuation and a DSO valuation can be significant. A $2M-revenue practice generating $400K EBITDA can transact at a substantial percentage of collections to a private buyer versus a multiple of EBITDA to a DSO buyer, which can create a gap worth hundreds of thousands of dollars. McLerran & Associates delivers a true side-by-side valuation that quantifies your practice’s worth in both markets, so you choose a path with full information rather than a guess.
Valuation is only one piece of preparation. Market dynamics and practice structure also influence what buyers will pay. For platform-grade groups, defined as those with $5M or more in EBITDA, 2026 DSO buyer demand shows its biggest surprises in the Midwest rather than the Sun Belt, per ProviderSignal’s Consolidation Index across major metros. Preparation also includes reducing owner dependence. Practices where the owner performs 90% or more of production can face a valuation reduction. Adding a producing associate can increase value by approximately one full turn of EBITDA.
Find out what your Arizona dental group may be worth in both markets by scheduling a confidential valuation discussion with McLerran & Associates.
LOI Terms That Shape Your DSO Outcome
The letter of intent, or LOI, is often the most consequential document in a DSO transaction. Once both sides sign, the seller usually enters 30 to 90 days of exclusivity, and the ability to renegotiate terms narrows. This stage is where McLerran & Associates acts as sell-side advisor and advocate, negotiating every structural element before exclusivity locks in.
The most critical terms to address at the LOI stage include:
-
Cash at close: The standard DSO structure delivers 60–85% cash at close, with the remainder in rollover equity and earnouts. Cash at close is the only guaranteed, take-home portion of the deal.
-
Equity structure: Rollover equity can sit at the joint-venture, or JV, level, which may provide ongoing distributions, or at the holding-company level, which can offer higher potential upside at a future recapitalization. Some JV structures also keep a portion of equity at the practice level.
-
Earnout terms: McLerran pushes for pro-rata provisions, so a near-miss on an EBITDA target still pays most of the earnout. The firm also works to align earnout periods with realistic integration timelines.
-
Exclusivity window: Shorter exclusivity generally favors the seller. McLerran negotiates to preserve competitive leverage as long as possible.
Learn how McLerran structures LOI terms to protect your leverage before exclusivity by scheduling a confidential consultation.
Due Diligence and Quality-of-Earnings Defense
After LOI execution, the buyer’s team conducts a quality-of-earnings, or QoE, review. This is a detailed examination of the financials that tests every add-back and normalization the seller claimed. Underprepared sellers can lose value at this stage because a weak EBITDA analysis often gets re-traded, and the headline number quietly shrinks.
McLerran & Associates builds diligence-grade work up front so the numbers can hold when buyers scrutinize them. During the QoE phase, the firm defends the EBITDA it underwrote and responds to buyer challenges with documented support. When appropriate, McLerran also reminds buyers that other vetted bidders remain in the process. Full due diligence in a DSO transaction can last several months and typically covers financials, clinical records, compliance, insurance contracts, real estate, and staff.
Associate retention is a critical diligence variable because associate departures during diligence commonly cause DSO deal collapse or material price reductions. Associate departures during diligence commonly cause DSO deal collapse or material price reductions. To reduce this risk, McLerran coordinates retention strategy before the process goes to market and works to ensure key providers are committed before buyers begin their review.
Protect your valuation through diligence by discussing McLerran’s quality-of-earnings defense strategy in a confidential consultation.
APA Terms That Affect Taxes and Risk
The asset purchase agreement, or APA, is the definitive legal document that governs the transaction. It covers purchase price allocation, working-capital true-ups, representations and warranties, indemnification, and non-compete terms. Most DSO transactions use an asset-sale structure, which affects how proceeds are taxed. Goodwill typically receives long-term capital gains treatment, while equipment may trigger ordinary income recapture.
Key APA negotiation points include:
-
Working-capital true-up: Working capital adjustments can change the final purchase price and are usually settled after closing.
-
Non-compete scope: Non-compete provisions form an important part of the APA. McLerran negotiates geography and duration to protect the seller’s future options.
-
Indemnification escrow: A 10–15% indemnification escrow is typically held for 12–18 months against representation and warranty breaches.
Integration, Compensation, and Staff Protection
Post-close integration is where the partnership can either meet expectations or fall short. A well-negotiated employment agreement, usually three to five years for DSO transactions, defines compensation structure, production expectations, and the seller’s clinical role going forward.
DSO buyers typically require three to five years of post-close work as an associate dentist with production-based compensation, which replaces prior owner distributions. McLerran models this compensation shift in its financial forecasting so sellers see the full economic picture, not just the headline multiple, before signing.
Staff protection is usually negotiated at the LOI and APA stages. McLerran identifies buyers whose integration model preserves existing team structures and patient relationships. Protecting goodwill through the transition can be as important as maximizing the headline number.
Clinical Autonomy and Arizona’s Regulatory Landscape
Arizona’s regulatory framework can be favorable for DSO transactions. Arizona is widely viewed as one of the more DSO-friendly jurisdictions because state statutes allow business entities to participate in dental practice operations while maintaining the dentist’s responsibility for clinical care. This structure can reduce uncertainty compared with more restrictive states.
A 2026 legislative change adds an important nuance. Arizona HB 2308, signed into law on June 4, 2026, prohibits dental insurers and any parent or holding company owning at least 10% of a dental insurer from owning any share of a dental practice. Sellers should confirm that a prospective DSO buyer has no insurance-company ownership ties that could create compliance issues under this statute.
Clinical autonomy provisions, including treatment planning, staffing decisions, and referral patterns, should appear explicitly in the management services agreement, or MSA, that governs the post-close relationship. The MSA signed with a DSO upon affiliation is a long-term agreement, which makes its terms some of the most consequential in the entire transaction.
Arizona Board Notifications and Compliance Steps
Ownership changes in Arizona dental practices trigger notification and filing obligations with the Arizona State Board of Dental Examiners, or AZSBDE. Sellers and their legal counsel can reduce closing risk by addressing these items before the transaction date.
-
Ownership-change notification: The AZSBDE requires timely notice of any change in the ownership or control of a dental practice. Failure to notify can result in regulatory penalties and may delay the effective date of the transition.
-
Fictitious-name filings: If the practice operates under a trade name or fictitious business name, updated filings that reflect the new ownership structure are required.
-
Insurance credentialing transfer: Insurance credentialing transfer for each PPO contract should be built into the overall transaction timeline. Major DSOs often use master credentialing relationships to speed this process.
-
DEA and controlled-substance registrations: Any DEA registration held by the selling entity must be addressed as part of the ownership transfer.
McLerran & Associates coordinates with dental-specific legal counsel to help ensure all regulatory notifications are completed on schedule and do not become a closing condition that delays the transaction.
Creating Competition Through a 45–60-Day Bid Process
Creating real buyer competition can be one of the most powerful ways to improve a seller’s outcome. A seller who talks to one DSO has one offer, limited leverage, and no way to know whether that buyer is the right fit. McLerran & Associates runs a structured, auction-like process, typically 45–60 days, that generates approximately 10 offers from a vetted pool of well-qualified buyers. DSOs known for poor post-close environments are removed from consideration before the process begins.
Practices taken to market through a structured multiple-buyer process receive final sale values that average 30% above what owners report when selling on their own. The process narrows from initial offers to in-person meetings or headquarters visits with the top one to three finalists. At that stage, McLerran forecasts each deal structure and focuses on the best fit and the highest, best terms.
See how a structured bid process can help maximize your outcome by starting a confidential consultation with McLerran & Associates.
Frequently Asked Questions
What is a realistic 2026 valuation for an Arizona dental group with $5M or more in annual collections?
Valuation for a group at this scale usually depends on EBITDA, not just revenue, and on factors such as provider depth, payer mix, hygiene contribution, owner dependence, and lease terms. Platform-grade groups at this size can attract strong multiples from private equity-backed DSO buyers, although the specific range depends on your practice’s fundamentals. Arizona’s position in the high-demand Sun Belt and Mountain West geography can support stronger multiples compared with many rural markets. A CPA-led EBITDA analysis that documents every add-back and produces a defensible, diligence-grade number can be a critical first step, rather than a rough estimate that may be re-traded later. McLerran & Associates delivers this analysis as the foundation of every engagement, along with a side-by-side comparison of what your group may be worth in both the private-buyer and DSO markets.
How do I identify a strong DSO buyer versus one that could put my retained equity at risk?
Not all DSOs perform the same, and as much as 40% of a deal can be paid in equity rather than cash, which makes buyer quality nearly as important as headline price. A strong DSO buyer usually shows consistent profitability across its existing offices, a management team with a track record of successful integrations, a well-capitalized private equity backer operating on a realistic timeline, and a history of satisfied selling doctors. McLerran & Associates vets buyers like investments and has blacklisted DSOs known for poor post-close environments, including undercapitalized platforms that emerged when capital flooded the space after COVID. Sellers in the McLerran process see a curated group of well-backed, well-run buyers.
What post-close work commitment should I expect in a DSO affiliation?
Most DSO transactions require a minimum three-to five-year post-close employment agreement. During this period, the selling doctor usually practices as a clinical associate at production-based compensation, typically a percentage of collections, rather than taking owner distributions. This shift can change annual income in a meaningful way, so McLerran models it explicitly in financial forecasts. That modeling allows owners to compare the after-tax economic outcome across deal structures and time horizons before signing. Owners who have already reduced chair time may be able to negotiate shorter or more flexible terms, although a multi-year clinical commitment remains standard in many DSO affiliations.
What Arizona regulatory steps are required when a DSO acquires a dental group?
Arizona requires timely notification to the Arizona State Board of Dental Examiners for any ownership change in a dental practice, along with updated fictitious-name filings if the practice operates under a trade name. Insurance credentialing transfer for each PPO contract usually runs as a parallel process and should be built into the overall timeline. DEA and controlled-substance registrations also need attention. A significant 2026 development is Arizona HB 2308, signed June 4, 2026, which bars dental insurers and their parent companies from owning any share of a dental practice. Sellers should confirm that a prospective buyer has no insurance-company ownership ties. McLerran coordinates with dental-specific legal counsel to help ensure all notifications and filings are completed on schedule.
How does a structured bid process actually increase my sale price?
Competition can be the main mechanism that increases price and improves terms. A seller negotiating directly with one DSO has limited leverage because that buyer sets both the terms and the valuation anchor. A structured process that generates multiple simultaneous offers pushes buyers to compete on price, cash-at-close percentage, equity structure, earnout terms, and post-close autonomy. McLerran’s process typically generates approximately 10 offers in 45–60 days, then narrows to the top finalists and uses that competitive tension to negotiate terms that a single-buyer conversation usually cannot match.
Conclusion
Selling an Arizona dental group to a DSO is often a once-in-a-career transaction. DSOs negotiate deals every week, while most practice owners sell only once. That imbalance can be a key reason why professional, dental-specific sell-side representation often shapes the outcome, not only on price but also on structure, clinical autonomy, staff protection, and the quality of the partner you select.
McLerran & Associates brings the same diligence-grade EBITDA analysis, structured competitive bid process, and sell-side advocacy described in this article to Arizona and the Mountain West through its Phoenix office, led by Brian Carroll. The firm’s national track record reflects a focus on running a disciplined process rather than simply listing practices.
If you own an Arizona dental group and are evaluating a DSO affiliation or doctor-to-doctor sale, a clear understanding of what your practice may be worth in both markets can be a practical first step. Schedule a free, confidential discovery call with McLerran & Associates — call (512) 900-7989, email info@dentaltransitions.com, or visit our contact page. The conversation is confidential, there is no obligation, and it may be one of the most valuable hours you spend this year.
